Abstract
Heart failure, a frequent complication of hypertension, is the primary risk factor of myocardial infarction. Therefore, it is important to find newer and effective treatments for hypertension comorbid with heart failure. A combination of amlodipine besylate and ligusticum, both known antihypertensives, was evaluated in hypertension complicated with heart failure with the goal of providing improved treatment. To this end, 172 hypertensive patients with heart failure received a conventional therapy or amlodipine besylate combined with ligusticum. Following treatment, all subjects were evaluated for clinical efficacy, safety, blood pressure, cardiac function, vascular endothelial function, and heart failure markers. The two groups were followed up for 1 year, and their prognosis and life quality were investigated. The treatment resulted in improvement in all markers, a higher total effectiveness rate with similar incidence of adverse reactions. Therefore, amlodipine besylate combined with ligusticum may be an effective and safe treatment for hypertension complicated with heart failure.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
